Chemical Structure (Pirfenidone 01)
Pirfenidone Capsule
Product Images NDC 76282-715
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 76282-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Pirfenidone 02)
This appears to be a table with headings indicating the percentage change in forced vital capacity (FVC) among patients using Pitenidone compared to those using a placebo. The table shows the number of patients (n) in each group and a percentage increase or decrease in FVC. There is also a column titled "Absolute Change" indicating the change in FVC from baseline to Week 52. However, the characters at the end of the text do not seem to be relevant or readable, so a complete assessment is not possible.*
Figure 2 (Pirfenidone 03)
Figure 3 (Pirfenidone 04)
Principal Display Panel (90 Capsules)
This is a medication called Pirfenidone, which is available in capsule form. Each capsule contains 267mg of Pirfenidone. The package insert contains information on dosage and administration of this medication. It is recommended to store Pirfenidone at a temperature of 25°C (77°F) or between 59° to 86°F as per USP guidelines. The manufacturer of Pirfenidone is ScieGen Pharmaceuticals, Inc. and is distributed by Exelan Pharmaceuticals, Inc. It should be kept out of children's reach.*
Principal Display Panel (270 Capsules)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
